Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Joseph Chao

Showing results (11-20 of 116) with videos related to

Pageof 12
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 7, 2020
A Space-Time Continuum for Immunotherapy Biomarkers in Gastroesophageal Cancer?Samuel J Klempner, Vivek Upadhyay, Joseph Chao
Journal of Hematology & Oncology|May 19, 2019
Progress and challenges in HER2-positive gastroesophageal adenocarcinomaDan Zhao, Samuel J Klempner, Joseph Chao
BMJ Case Reports|November 18, 2016
Case of Steven-Johnson Syndrome in a male with breast cancer secondary to docetaxel/cyclophosphamide therapyBenjamin Jarrett, Sehem Ghazala, Joseph Chao, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|October 18, 2008
Modern staging and utility of PET imaging in esophageal cancer managementKwang-Yu Chang, Jang-Yang Chang, Joseph Chao, et al.
Gastrointestinal Cancer : Targets and Therapy|August 1, 2017
PD-1 and PD-L1 as emerging therapeutic targets in gastric cancer: current evidencePhu N Tran, Sarmen Sarkissian, Joseph Chao, et al.
World Journal of Gastroenterology|July 12, 2018
Advances in immuno-oncology biomarkers for gastroesophageal cancer: Programmed death ligand 1, microsatellite instability, and beyondEmily M Lin, Jun Gong, Samuel J Klempner, et al.
Cancer Management and Research|March 27, 2023
Role of PD-1 Inhibitors in the Treatment of Esophagogastric Adenocarcinoma: Patient Selection and Reported OutcomesRaisa Epistola, Rubens Sperandio, Zev Wainberg, et al.
Translational Gastroenterology and Hepatology|September 28, 2019
Checkpoint inhibition in advanced gastroesophageal cancer: clinical trial data, molecular subtyping, predictive biomarkers, and the potential of combination therapiesJeremy Chuang, Joseph Chao, Andrew Hendifar, et al.
Antimicrobial Agents and Chemotherapy|July 18, 2018
Screening of Preselected Libraries Targeting Mycobacterium abscessus for Drug DiscoveryAdrian Richter, Angelika Strauch, Joseph Chao, et al.
Journal of Gastrointestinal Oncology|July 13, 2018
Refining the management of resectable esophagogastric cancer: FLOT4, CRITICS, OE05, MAGIC-B and the promise of molecular classificationJeremy Chuang, Jun Gong, Samuel J Klempner, et al.
Pageof 12

Showing results (11-20 of 116) with videos related to

Sort By:
Pageof 12
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 7, 2020
A Space-Time Continuum for Immunotherapy Biomarkers in Gastroesophageal Cancer?Samuel J Klempner, Vivek Upadhyay, Joseph Chao
Journal of Hematology & Oncology|May 19, 2019
Progress and challenges in HER2-positive gastroesophageal adenocarcinomaDan Zhao, Samuel J Klempner, Joseph Chao
BMJ Case Reports|November 18, 2016
Case of Steven-Johnson Syndrome in a male with breast cancer secondary to docetaxel/cyclophosphamide therapyBenjamin Jarrett, Sehem Ghazala, Joseph Chao, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|October 18, 2008
Modern staging and utility of PET imaging in esophageal cancer managementKwang-Yu Chang, Jang-Yang Chang, Joseph Chao, et al.
Gastrointestinal Cancer : Targets and Therapy|August 1, 2017
PD-1 and PD-L1 as emerging therapeutic targets in gastric cancer: current evidencePhu N Tran, Sarmen Sarkissian, Joseph Chao, et al.
World Journal of Gastroenterology|July 12, 2018
Advances in immuno-oncology biomarkers for gastroesophageal cancer: Programmed death ligand 1, microsatellite instability, and beyondEmily M Lin, Jun Gong, Samuel J Klempner, et al.
Cancer Management and Research|March 27, 2023
Role of PD-1 Inhibitors in the Treatment of Esophagogastric Adenocarcinoma: Patient Selection and Reported OutcomesRaisa Epistola, Rubens Sperandio, Zev Wainberg, et al.
Translational Gastroenterology and Hepatology|September 28, 2019
Checkpoint inhibition in advanced gastroesophageal cancer: clinical trial data, molecular subtyping, predictive biomarkers, and the potential of combination therapiesJeremy Chuang, Joseph Chao, Andrew Hendifar, et al.
Antimicrobial Agents and Chemotherapy|July 18, 2018
Screening of Preselected Libraries Targeting Mycobacterium abscessus for Drug DiscoveryAdrian Richter, Angelika Strauch, Joseph Chao, et al.
Journal of Gastrointestinal Oncology|July 13, 2018
Refining the management of resectable esophagogastric cancer: FLOT4, CRITICS, OE05, MAGIC-B and the promise of molecular classificationJeremy Chuang, Jun Gong, Samuel J Klempner, et al.
Pageof 12